Mediation meta-analysis of 13 FDA-submitted enriched-enrolment randomised withdrawal trials of opioids for chronic pain (5,070 participants): withdrawal symptoms did not significantly mediate pain benefit overall (2% of effect), but did in 3 trials (8% to 28%).
Meta-analysisn = 5,070
Miller et al. The impact of opioid withdrawal symptoms on pain outcomes in enriched enrollment randomized withdrawal trials: a mediation meta-analysis of trials submitted to the US Food and Drug Administration